Endolysin variant
AssigneeSasinapas Co., Ltd.
InventorMartin GRIESSL
Life of this patent
Estimating the term…
Loading patent…
AssigneeSasinapas Co., Ltd.
InventorMartin GRIESSL
Estimating the term…
The present invention relates to the field of antimicrobial enzymes. In particular, the present invention relates to a polypeptide comprising an amino acid sequence exhibiting at least 90% sequence identity with the sequence of SEQ ID NO:1, with the proviso that the polypeptide does neither comprise the sequence according to SEQ ID NO:2, nor the sequence according to SEQ ID NO:3, nor the sequence according to SEQ ID NO:4. The present invention relates also to nucleic acids encoding an inventive polypeptide, vectors or bacteriophages comprising an inventive nucleic acid as well as host cells comprising an inventive polypeptide, nucleic acid, vector, and/or bacteriophage. Similarly, the present invention relates to compositions comprising a polypeptide, nucleic acid, vector, bacteriophage, and/or host cell according to the present invention.
A polypeptide comprising an amino acid sequence exhibiting at least 97% sequence identity with the sequence of SEQ ID NO:1, wherein SEQ ID NO:1 is characterized by
A polypeptide comprising an amino acid sequence exhibiting at least 90% sequence identity with the sequence of SEQ ID NO:
Dependencies are inferred from the claim text.